Table 1 Baseline parameters of 15 patients with microangiopathic ischemic stroke and 22 control group persons and the mfVEP subgroup of 13 microangiopathic ischemic stroke patients and 13 controls. Absolute numbers and percentages or median with interquartile range are provided for demographics, risk factors and visual acuity

Median age in years (interquartile range), [age range]

63 (50–71), [45–79]

53 (46–55), [21–80]

Mann Whitney U test

p < 0.05

63 (53.5–73), [45–79]

55 (48.5–66.5), [44–80]

Mann Whitney U test

n.s.

Male gender

10 (67%)

13 (59%)

Fisher’s exact test

n.s.

9 (69%)

10 (77%)

Fisher’s exact test

n.s.

Arterial Hypertension

12 (80%)

4 (18%)

Fisher’s exact test

p < 0.05

10 (77%)

2 (15%)

Fisher’s exact test

n.s.

Diabetes mellitus

5 (33%)

2 (9%)

Fisher’s exact test

n.s.

3 (23%)

2 (15%)

Fisher’s exact test

n.s.

Vascular disease

4 (27%)

0 (0%)

Fisher’s exact test

p < 0.05

4 (31%)

0 (0%)

Fisher’s exact test

n.s.

Smoking

10 (67%)

1 (5%)

Fisher’s exact test

p < 0.01

9 (69%)

1 (8%)

Fisher’s exact test

p < 0.01

Coronary heart disease

2 (13%)

0 (0%)

Fisher’s exact test

n.s.

2 (15%)

0 (0%)

Fisher’s exact test

n.s.

Hyperlipidemia

10 (67%)

3 (14%)

Fisher’s exact test

p < 0.01

9 (69%)

3 (23%)

Fisher’s exact test

p < 0.01

Median corrected visual acuity in log MAR units (interquartile range)

0.01 (−0.05 to 0.07) (N = 28 eyes)

0.00 (− 0.12 to + 0.12) (N = 16 eyes)

Mann Whitney U test

p < 0.05

0.01 (0 to + 0.1) (N = 24 eyes)

0.00 (− 0.1 to + 0.1) (N = 14 eyes)

Mann Whitney U test

n.s.